Your browser doesn't support javascript.
loading
Newcastle Disease Virus (NDV)-based vaccine candidate against SARS-CoV-2 Omicron by intranasal immunization.
Zhang, Qiu-Yan; Zhang, Hong-Qing; Zhang, Ya-Nan; Zhang, Zhe-Rui; Li, Xiao-Dan; Hao, Meng-Chan; Zhang, Yang; Li, Jia-Qi; Hu, Yan-Yan; Chen, Xiao-Ling; Wang, Jing; Shi, Yu-Jia; Deng, Cheng-Lin; Chen, Jian-Jun; Ye, Han-Qing; Zhang, Bo.
Affiliation
  • Zhang QY; Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China.
  • Zhang HQ; Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China; University of Chinese Academy of Sciences, Beijing, 100049, China.
  • Zhang YN; Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China.
  • Zhang ZR; Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China.
  • Li XD; Hunan Normal University, School of Medicine, Changsha, 410081, China.
  • Hao MC; Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China; University of Chinese Academy of Sciences, Beijing, 100049, China.
  • Zhang Y; University of Science and Technology of China, Department of Life Sciences and Medicine, Hefei, 230026, China.
  • Li JQ; Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China; University of Chinese Academy of Sciences, Beijing, 100049, China.
  • Hu YY; Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China; University of Chinese Academy of Sciences, Beijing, 100049, China.
  • Chen XL; Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China; University of Chinese Academy of Sciences, Beijing, 100049, China.
  • Wang J; Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China; University of Chinese Academy of Sciences, Beijing, 100049, China.
  • Shi YJ; Hunan Normal University, School of Medicine, Changsha, 410081, China.
  • Deng CL; Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China.
  • Chen JJ; Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China; University of Chinese Academy of Sciences, Beijing, 100049, China.
  • Ye HQ; Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China; University of Chinese Academy of Sciences, Beijing, 100049, China. Electronic address: yehq@wh.iov.cn.
  • Zhang B; Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China; University of Chinese Academy of Sciences, Beijing, 100049, China. Electronic address: zhangbo@wh.iov.cn.
Antiviral Res ; 220: 105757, 2023 12.
Article in En | MEDLINE | ID: mdl-37984567
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Blood Group Antigens / Vaccines / COVID-19 Limits: Animals / Humans Language: En Journal: Antiviral Res Year: 2023 Document type: Article Affiliation country: China
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Blood Group Antigens / Vaccines / COVID-19 Limits: Animals / Humans Language: En Journal: Antiviral Res Year: 2023 Document type: Article Affiliation country: China